Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
2006
Clinical guidelines for postpartum women and infants in primary care–a systematic review
2014 Standout
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
2013
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
2010
Modeling Serum Level of S100β and Bispectral Index to Predict Outcome After Cardiac Arrest
2013
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?
2010
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Inhibition of NADPH oxidase 2 (NOX2) prevents sepsis-induced cardiomyopathy by improving calcium handling and mitochondrial function
2017
Amino-Terminal Pro–B-Type Natriuretic Peptide Testing for the Diagnosis or Exclusion of Heart Failure in Patients with Acute Symptoms
2008
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management
2007
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
2012
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Cushing's syndrome
2015 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin
2001
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
2006
Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
2011
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
2008
Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
2010
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
2020 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome
2010
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization
2008
Steroidogenesis-disrupting compounds can be effectively studied for major fertility-related endpoints using in vitro cultured mouse follicles
2008
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
Fertility and infertility: Definition and epidemiology
2018 Standout
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Inhaled and nasal corticosteroids: safety aspects*
2000
Polycystic Ovary Syndrome and Oocyte Developmental Competence
2008
Designing hydrogels for controlled drug delivery
2016 Standout
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
2006
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits
2011
Cushing's syndrome in pregnancy treated by ketoconazole: Case report and review of the literature
1999
Testosterone receptor blockade restores cellular immunity in male mice after burn injury
2001
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia
2009
Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism
2010
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Polycystic ovary syndrome
2016 Standout
Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data
2013
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
2009
Industry sponsorship and research outcome
2012 Standout
Anti-Mullerian hormone: a new marker for ovarian function
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update
2008
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism
1999
Dehydroepiandrosterone: Biosynthesis and Metabolism in the Brain
1999
Efficacy and Safety of Histrelin Subdermal Implant in Patients With Advanced Prostate Cancer
2006
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart Failure
2009
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
2007
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Biomedical applications of hydrogels: A review of patents and commercial products
2014 Standout
Industry sponsorship and research outcome
2017 Standout
Works of Nurit Algur being referenced
Modeling Serum Biomarkers S100 Beta and Neuron-Specific Enolase as Predictors of Outcome After Out-of-Hospital Cardiac Arrest
2012
N-Terminal-proB-Type Natriuretic Peptide as a Marker for Acute Anthracycline Cardiotoxicity in Children
2007
Incidence and Significance of a Positive Troponin Test in Bacteremic Patients Without Acute Coronary Syndrome
2008
Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism
2005
Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer
2002
Adrenal Suppression Among Asthmatic Children Receiving Chronic Therapy with Inhaled Corticosteroid with and Without Spacer Device
1996
Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro
1994
Evaluation of Discharge Management in the Prediction of Hyperbilirubinemia: The Jerusalem Experience
2007
AN IMPLANT RELEASING THE GONADOTROPIN HORMONE-RELEASING HORMONE AGONIST HISTRELIN MAINTAINS MEDICAL CASTRATION FOR UP TO 30 MONTHS IN METASTATIC PROSTATE CANCER
2000
Comparison of N-terminal Pro-B-Type Natriuretic Peptide Levels in Critically Ill Children With Sepsis Versus Acute Left Ventricular Dysfunction
2006
AN IMPLANT RELEASING THE GONADOTROPIN HORMONE-RELEASING HORMONE AGONIST HISTRELIN MAINTAINS MEDICAL CASTRATION FOR UP TO 30 MONTHS IN METASTATIC PROSTATE CANCER
2000